← Leaderboards
William Raymond Lagor
Baylor College Of Medicine
$11,150,642
Attributed
$15,007,744
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,615,706 · 6
By mechanism
R01$8,226,090 · 2
U42$6,092,467 · 3
UG3$2,297,149 · 1
Top collaborators
- Jason D Heaney8 shared
- Mary E Dickinson6 shared
- Gang Bao3 shared
- Christopher John Walkey2 shared
- Noah Freeman Shroyer1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Sharon Emma Plon$39,994,796
- Donald W. Parsons$9,398,880
- Amy Lynn McGuire$13,971,446
- Richard R Sharp$7,704,962
- Brendan Hl Lee$62,781,623
Others in their field
Other Emerging Leaders on “Genome Editing”
- Dale Sandler · Social And Scientific Systems, Inc.$12,382,171
- Benjamin E Deverman · Broad Institute, Inc.$10,165,764
- Yin Shen · University Of California, San Francisco$9,676,164
- Jesse M Engreitz · Stanford University$9,274,327
- William H. Peranteau · Children'S Hosp Of Philadelphia$7,624,302
- James Even Voss · Scripps Research Institute, The$6,607,823
Research focus
Genome EditingGenesKnockout MiceMouse ModelLiverCellsIn VivoGeneticPhenotypeGene TherapyTechnologyProgramsSomatic Cell Gene EditingAllelesProteinsSiteHuman DiseaseTissuesCholesterolSafetyBaseImmune ResponseReporterPlasma
Grant awards (28)
BCM/RICE GENOME EDITING TESTING CENTER$796,481
U42 · FY2025 · OD
Physiological Dissection of the Mevalonate Pathway$720,822
R01 · FY2025 · DK · contact PI
Genetic Repair of Familial Hypercholesterolemia$558,477
R01 · FY2025 · HL · contact PI
Genome Editing and Biological Effects Testing Section$491,635
U42 · FY2025 · OD · contact PI
Genetic Repair of Familial Hypercholesterolemia$547,307
R01 · FY2024 · HL · contact PI
BCM/RICE GENOME EDITING TESTING CENTER$811,481
U42 · FY2023 · OD
Genetic Repair of Familial Hypercholesterolemia$558,477
R01 · FY2023 · HL · contact PI
Physiological Dissection of the Mevalonate Pathway$532,092
R01 · FY2023 · DK · contact PI
Genome Editing and Biological Effects Testing Section$470,695
U42 · FY2023 · OD · contact PI
BCM-Rice resource for the analysis of somatic gene editing in mice$675,697
U42 · FY2022 · OD
Genetic Repair of Familial Hypercholesterolemia$573,477
R01 · FY2022 · HL · contact PI
Physiological Dissection of the Mevalonate Pathway$532,092
R01 · FY2022 · DK · contact PI
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity$762,524
UG3 · FY2021 · HL
BCM-Rice resource for the analysis of somatic gene editing in mice$685,005
U42 · FY2021 · OD
Genetic Repair of Familial Hypercholesterolemia$645,390
R01 · FY2021 · HL · contact PI
Physiological Dissection of the Mevalonate Pathway$532,092
R01 · FY2021 · DK · contact PI
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity$758,237
UG3 · FY2020 · HL
BCM-Rice resource for the analysis of somatic gene editing in mice$695,141
U42 · FY2020 · OD
Genetic Repair of Familial Hypercholesterolemia$645,390
R01 · FY2020 · HL · contact PI
Physiological Dissection of the Mevalonate Pathway$532,022
R01 · FY2020 · DK · contact PI
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity$776,388
UG3 · FY2019 · HL
BCM-Rice resource for the analysis of somatic gene editing in mice$719,279
U42 · FY2019 · OD
Genetic Repair of Familial Hypercholesterolemia$645,390
R01 · FY2019 · HL · contact PI
BCM-Rice resource for the analysis of somatic gene editing in mice$394,974
U42 · FY2019 · OD
Genetic Repair of Familial Hypercholesterolemia$581,448
R01 · FY2018 · HL · contact PI
BCM-Rice resource for the analysis of somatic gene editing in mice$352,079
U42 · FY2018 · OD
Genetic Repair of Familial Hypercholesterolemia$25,541
R01 · FY2018 · HL · contact PI
Genetic Repair of Familial Hypercholesterolemia$596,073
R01 · FY2017 · HL · contact PI